PI

Piers Ingram

CEO & Co-Founder at Hummingbird Bioscience

Singapore, Singapore

About

Piers Ingram is based out of Singapore and is the CEO and Co-Founder of Callio Therapeutics. Piers attended Imperial College London.

Position in the VCSift Database

  • 616 investors hold the CEO & Co-Founder role in VCSift. Piers Ingram is one of them.
  • 1,940 investors are based in Singapore, Central Region, Singapore.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Contact Information

em••••@example.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Piers

Search Investors